[ad_1]
Another Covid-19 vaccine is about to be approved in the US An FDA panel of experts voted Friday in favor of the emergency approval of Johnson & Johnson’s vaccine. The vote is not binding. However, as a general rule, FDA follows the recommendations of this commission in a very short time.
So far, the Biontech / Pfizer and Moderna Covid-19 vaccines have been approved in the US For the European Union, the EMA wants to decide on the conditional marketing authorization for the Johnson & Johnson vaccine in mid-March. Bahrain was the first country in the world to issue an emergency clearance to the agent on Thursday.
Compared to the other vaccines that have already been approved, Johnson & Johnson’s has the advantage that a single dose should suffice instead of two doses. In addition, the preparation does not have to be stored frozen, which facilitates its distribution.
At the end of January, Johnson & Johnson reported a 66 percent effectiveness for the agent in protecting against moderate to severe COVID-19 courses in its global study with about 44,000 participants. To prevent hospitalization, the vaccine was 85 percent effective 14 days after vaccination and 100 percent effective 28 days.
